China Primary Health Care Foundation, WeDoctor, and Astellas Launch Internet Healthcare Public Welfare Project

As the phased achievements of epidemic prevention and control are further consolidated, offlineGradual Resumption of Operations in Healthcare InstitutionsPatient ConsultationOrder, but go out for medical consultationNumerous inconveniences and risks of cross-infection still persist. ForConvenient for chronic diseases and minor ailmentsPatientSeeking Medical Advice and Medication，Alleviate the Pressure on Offline Medical Institutions，April 27Recently, by ChinaPrimary Health Care FoundationInitiate,NumbersHealthPlatformMicroMedicineandAstellas Pharma (China）LimitedCompanyJoint Launch“InternetPublic Welfare Project for Enhancing Patient Services in Healthcare”，This project will, over the next two months, throughOnline Free Clinic,Live StreamingDeng InternetMethod, forPatients receive online medical consultation and health education services.

With socioeconomic development and the accelerating pace of life, the number of individuals with chronic diseases in China has reached approximately 300 million. According to official statistics, prostate cancer is the second most common malignant tumor among men worldwide and has become the most prevalent male urological malignancy in China. The number of people with hyperuricemia in China has reached 170 million, of whom 80 million suffer from gout.

During the epidemic, many patients with severe and chronic conditions urgently needed professional medical guidance, and the advantages of internet-based diagnosis and treatment—such as professionalism, efficiency, and convenience—gradually became prominent. On February 3, the General Office of the National Health Commission issued the "Notice on Strengthening Information Technology Support for the Prevention and Control of Novel Coronavirus Pneumonia," requiring full leverage of the unique advantages of internet hospitals and online consultation services. It encouraged the provision of online follow-up consultations for certain common and chronic diseases, as well as medication delivery services, to reduce the risk of cross-infection among other patients seeking offline medical care.

Starting from April 27, nearly 300 experts in the fields of transplantation, urology, and rheumatology and immunology from multiple Grade A tertiary hospitals will be mobilized to join the WeDoctor platform, providing patients with free consultation services. In addition, these medical experts will conduct live health education sessions on the WeDoctor platform, offering remote “face-to-face” interactions to address patients’ questions and concerns.

China Primary Health Care Foundation is a national public fundraising foundation initiated and established by the Central Committee of the Chinese Peasants and Workers Democratic Party, supervised by the National Health Commission, with the mission of funding and developing primary health care services at the grassroots level, particularly in impoverished rural areas.

WeDoctor, an internationally leading digital health platform, has been committed to providing high-quality, efficient, and accessible medical and healthcare services to users for the past decade, safeguarding the health of hundreds of millions. As of February 2020, WeDoctor Internet General Hospital operated 12 physical medical institutions and 21 internet hospitals, connecting more than 3,200 hospitals across China, over 400,000 physicians, and 212 million real-name registered users, with a cumulative service volume of nearly 1 billion patient visits.

Headquartered in Tokyo, Japan, Astellas Pharma Inc. is a pharmaceutical company dedicated to improving human health worldwide by providing innovative and reliable medicines. At the forefront of healthcare transformation, Astellas is committed to turning innovative science into medical solutions that deliver value and hope to patients around the globe. Astellas Pharmaceutical (China) Co., Ltd. is a wholly-owned subsidiary of Astellas Pharma Group in China.

In the future, the three parties will jointly leverage their respective strengths to efficiently assist physicians in precisely combating diseases, providing patients with a new model of innovative health management.